Latest News

As Chairperson, Dr. Mekdes will lead deliberations and decision-making among the 47 Member States of the WHO African Region throughout the session.

Lupus is a chronic autoimmune disease that can affect several organs, including the joints, skin, kidneys, brain and cardiovascular system.

The two firms launched Metsera in 2022, and the biotech emerged from stealth in 2024 after securing US$290 million in financing.

The antisense oligonucleotide (ASO) medicine, which GSK will market in Japan as Hibsago, is approved for adults with hepatitis B who meet specified viral markers.

McKesson expects the acquisition to strengthen its oncology and multi-specialty strategy while broadening the services it provides to biopharmaceutical companies.

Biohaven is currently evaluating the therapy in the Phase II/III RISE3 study, with results expected in the second half of 2026.

The agreement covers 129 countries, including all African nations, and gives Aspen rights across both public and private healthcare sectors.

Dr Tapela holds a Doctor of Medicine (MD) degree and a Master of Public Health (MPH) degree from Harvard University.

Minapharm’s candidate is the fifth Bundibugyo-specific vaccine supported by CEPI as the Democratic Republic of the Congo (DRC) responds to a rapidly escalating outbreak.

The replenishment will restore supplies at facilities in Tshwane, Johannesburg and Sedibeng that experienced temporary shortages after demand exceeded initial projections following the programme’s rollout in June 2026.